nasal polyps

News
Card image cap

AZ's Fasenra on target in nasal polyps trial

AstraZeneca’s Fasenra (benralizumab) injected drug cuts the size of nasal polyps and nasal blockage in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).